- Home
- GERN vs FWRD Comparison
GERN vs FWRD Comparison
Compare GERN & FWRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- FWRD
- Stock Information
- Founded
- GERN 1990
- FWRD 1981
- Country
- GERN United States
- FWRD United States
- Employees
- GERN N/A
- FWRD N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- FWRD Oil Refining/Marketing
- Sector
- GERN Health Care
- FWRD Consumer Discretionary
- Exchange
- GERN Nasdaq
- FWRD Nasdaq
- Market Cap
- GERN 823.0M
- FWRD 909.4M
- IPO Year
- GERN 1996
- FWRD 1993
- Fundamental
- Price
- GERN $1.27
- FWRD $26.73
- Analyst Decision
- GERN Buy
- FWRD Buy
- Analyst Count
- GERN 8
- FWRD 4
- Target Price
- GERN $3.71
- FWRD $34.67
- AVG Volume (30 Days)
- GERN 5.5M
- FWRD 484.0K
- Earning Date
- GERN 11-06-2025
- FWRD 11-03-2025
- Dividend Yield
- GERN N/A
- FWRD N/A
- EPS Growth
- GERN N/A
- FWRD N/A
- EPS
- GERN N/A
- FWRD N/A
- Revenue
- GERN $164,447,000.00
- FWRD $2,520,908,000.00
- Revenue This Year
- GERN $175.15
- FWRD $4.64
- Revenue Next Year
- GERN $56.61
- FWRD $7.53
- P/E Ratio
- GERN N/A
- FWRD N/A
- Revenue Growth
- GERN 11877.20
- FWRD 35.18
- 52 Week Low
- GERN $1.09
- FWRD $9.79
- 52 Week High
- GERN $4.83
- FWRD $40.92
- Technical
- Relative Strength Index (RSI)
- GERN 41.64
- FWRD 37.21
- Support Level
- GERN $1.23
- FWRD $29.05
- Resistance Level
- GERN $1.33
- FWRD $30.62
- Average True Range (ATR)
- GERN 0.07
- FWRD 1.15
- MACD
- GERN -0.02
- FWRD -0.31
- Stochastic Oscillator
- GERN 13.79
- FWRD 4.36
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About FWRD Forward Air Corporation
Forward Air Corp is an asset-light freight and logistics company. The company's operating segment includes Expedited Freight, Omni Logistics, and Intermodal and Corporate. The company generates maximum revenue from the Omni Logistics segment. The expedited Freight segment operates a comprehensive national network to provide expedited regional, inter-regional, and national LTL (less-than-truckload) services. It also offers customers local pick-up and delivery and other services including final mile, truckload, shipment consolidation and deconsolidation, warehousing, customs brokerage, and other handling. The Company conducts business in the United States, Canada, and Mexico.